- Report
- June 2024
- 185 Pages
Global
From €3998EUR$4,500USD£3,468GBP
- Report
- May 2024
- 182 Pages
Global
From €3998EUR$4,500USD£3,468GBP
- Report
- May 2024
- 187 Pages
Global
From €3998EUR$4,500USD£3,468GBP
- Report
- August 2024
- 150 Pages
Global
From €3332EUR$3,750USD£2,890GBP
- Report
- February 2024
- 120 Pages
Global
From €4221EUR$4,750USD£3,661GBP
- Report
- May 2024
- 106 Pages
North America
From €3066EUR$3,450USD£2,659GBP
- Report
- May 2024
- 140 Pages
Global
From €4397EUR$4,949USD£3,814GBP
- Report
- July 2023
- 220 Pages
Global
€4261EUR$4,795USD£3,695GBP
- Report
- November 2022
- 303 Pages
Global
From €3199EUR$3,600USD£2,774GBP
- Report
- November 2021
- 656 Pages
Global
From €4443EUR$5,000USD£3,853GBP
- Report
- November 2021
- 1032 Pages
Global
From €4443EUR$5,000USD£3,853GBP
- Book
- March 2010
- 784 Pages
- Book
- July 2019
- 352 Pages
The Protein Biomarker market is a subset of the Proteomics industry, which focuses on the study of proteins and their functions. Protein biomarkers are proteins that can be used to detect and diagnose diseases, as well as to monitor the progression of a disease or the effectiveness of a treatment. They are used in a variety of applications, such as drug discovery, diagnostics, and personalized medicine.
The Protein Biomarker market is driven by the increasing demand for personalized medicine, as well as the growing prevalence of chronic diseases. Additionally, technological advancements in proteomics have enabled the development of more accurate and cost-effective biomarkers.
Some companies in the Protein Biomarker market include Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Merck KGaA, and PerkinElmer. Show Less Read more
